Overview

Expanded Access Study for Renal Transplant Patients With Envarsus XR ™

Status:
Approved for marketing
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Open label, multi-center, expanded access study for renal transplant patients with once daily Envarsus XR (Tacrolimus).
Details
Lead Sponsor:
Veloxis Pharmaceuticals
Treatments:
Tacrolimus